Form 4: Vicor Corp Insider Sells Shares Under 10b5-1 Plan

Philip D. Davies, VP Global Sales & Marketing and Director at Vicor Corp, reported the sale of common stock valued at over $1.1 million through a pre-arranged 10b5-1 trading plan.

Summary

• Philip D. Davies, a Director and VP Global Sales & Marketing at Vicor Corp (VICR), has reported transactions involving the company's common stock.
• On May 1, 2026, Davies acquired 3,073 shares of common stock at a price of $30.98 per share, likely through the exercise of stock options.
• Concurrently, Davies disposed of a total of 4,893 shares of common stock through multiple sales transactions on the same date.
• These sales occurred at weighted average prices ranging from $264.07 to $274.43 per share.
• The sales were executed under a Rule 10b5-1 trading plan adopted by Davies on November 21, 2025, which is designed to satisfy affirmative defense conditions for insider trading.
• Following these transactions, Davies beneficially owns 2,020 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While significant insider selling can be a negative signal, the execution under a pre-established 10b5-1 plan mitigates concerns about opportunistic trading based on non-public information.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned and potentially less market-sensitive sales.
• The acquisition of shares at a lower price ($30.98) suggests potential benefit from option exercise prior to sales at higher market prices.

Negatives

• Significant sale of common stock by a key executive (VP Global Sales & Marketing and Director).
• The total value of shares sold is substantial, exceeding $1.1 million based on the reported weighted average prices.

Risks

• Insider selling, even if under a 10b5-1 plan, can sometimes be interpreted negatively by the market, potentially impacting share price.
• The substantial volume of shares sold by a high-ranking executive might signal a lack of confidence in near-term stock performance, although the 10b5-1 plan mitigates this interpretation.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Industry Context

StockSavvy.ai notes that insider selling, particularly by senior executives like a VP of Sales and a Director, is a common event. However, the execution of these sales under a Rule 10b5-1 plan is a standard practice designed to allow insiders to diversify their holdings or raise liquidity without being perceived as trading on material non-public information. The prices at which the shares were sold reflect the prevailing market rates for Vicor Corp stock during the reporting period.

Stakeholder Impact

• Shareholders: May view insider selling with caution, though the 10b5-1 plan provides a degree of reassurance.
• Employees: May interpret the sales as a sign of executive confidence in the company's long-term prospects, especially given the option exercise.
• Management: The filing confirms adherence to established governance practices regarding insider trading.

Next Steps

• Monitor future Form 4 filings for any further transactions by Philip D. Davies or other Vicor Corp insiders.
• Observe market reaction to this filing, although the 10b5-1 plan should limit significant impact.

Key Dates

Recommendation

The filing reports routine insider transactions executed under a Rule 10b5-1 plan. While significant selling by an executive can be a concern, the pre-planned nature of the trades suggests it's for personal financial management rather than a signal of negative company outlook. Therefore, a 'hold' recommendation is appropriate, pending other material company news.

Keywords

Vicor Corp, VICR, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Philip D. Davies, Common Stock, SEC Filing, Executive Sales